Relative Biological Effectiveness and Non-Poissonian Distribution of Dicentric Chromosome Aberrations following Californium-252 Neutron Exposures of Human Peripheral Blood Lymphocytes.


Journal

Radiation research
ISSN: 1938-5404
Titre abrégé: Radiat Res
Pays: United States
ID NLM: 0401245

Informations de publication

Date de publication:
01 02 2021
Historique:
received: 24 09 2019
accepted: 30 10 2020
pubmed: 6 1 2021
medline: 23 4 2021
entrez: 5 1 2021
Statut: ppublish

Résumé

Cells exposed to fast neutrons often exhibit a non-Poisson distribution of chromosome aberrations due to the high ionization density of the secondary reaction products. However, it is unknown whether lymphocytes exposed to californium-252 (252Cf) spectrum neutrons, of mean energy 2.1 MeV, demonstrate this same dispersion effect at low doses. Furthermore, there is no consensus regarding the relative biological effectiveness (RBE) of 252Cf neutrons. Dicentric and ring chromosome formations were assessed in human peripheral blood lymphocytes irradiated at doses of 12-135 mGy. The number of aberrations observed were tested for adherence to a Poisson distribution and the maximum low-dose relative biological effectiveness (RBEM) was also assessed. When 252Cf-irradiated lymphocytes were examined along with previously published cesium-137 (137Cs) data, RBEM values of 15.0 ± 2.2 and 25.7 ± 3.8 were found for the neutron-plus-photon and neutron-only dose components, respectively. Four of the five dose points were found to exhibit the expected, or close to the expected non-Poisson over-dispersion of aberrations. Thus, even at low doses of 252Cf fast neutrons, when sufficient lymphocyte nuclei are scored, chromosome aberration clustering can be observed.

Identifiants

pubmed: 33400791
pii: 450245
doi: 10.1667/RR15528.2
doi:

Substances chimiques

Cesium Radioisotopes 0
Cesium-137 4T2E65IAR7
Californium 975X05H15A
Californium-252 9J0Y94YP8Y

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

211-217

Informations de copyright

©2021 by Radiation Research Society. All rights of reproduction in any form reserved.

Auteurs

Laura C Paterson (LC)

Canadian Nuclear Laboratories, Chalk River, Canada.
McGill University, Montreal, Canada.

Andre Yonkeu (A)

Canadian Nuclear Laboratories, Chalk River, Canada.

Fawaz Ali (F)

Canadian Nuclear Laboratories, Chalk River, Canada.

Nicholas D Priest (ND)

Canadian Nuclear Laboratories, Chalk River, Canada.

Douglas R Boreham (DR)

McMaster University, Hamilton, Canada.
Northern Ontario School of Medicine, Sudbury, Canada.

Colin B Seymour (CB)

McMaster University, Hamilton, Canada.

Farrah Norton (F)

Canadian Nuclear Laboratories, Chalk River, Canada.

Richard B Richardson (RB)

Canadian Nuclear Laboratories, Chalk River, Canada.
McGill University, Montreal, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH